Who invested in Inhibrx?
Inhibrx's investors include RA Capital Management, Perceptive Advisors, Lilly Asia Ventures, TCG and TCG Crossover, and 1 more on record.
United States · Funded startup
3 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 8 months ago
Funding summaryUpdated 26 Oct 2026
$265Mraised across 3 rounds since 2019, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
Source recorded
From the SEC filings it signed: 3 on the team.
On the board, as filediDouglas ForsythJon KayyemKimberly ManhardKristiina Vuori
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Inhibrx's investors include RA Capital Management, Perceptive Advisors, Lilly Asia Ventures, TCG and TCG Crossover, and 1 more on record.
Inhibrx has raised $265M across 3 rounds since 2019.
Inhibrx's most recent round was a Debt of $75M in Mar 2026.
Inhibrx's largest round on record is $150M (Debt), in Jan 2025.
Inhibrx's first round on record, in May 2019, was backed by Viking Global.
Inhibrx's latest named round is a Debt, in Mar 2026.
Inhibrx is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.